The carbonyl reductase from Candida parapsilosis (CPCR2) is a versatile biocatalyst for the production of optically pure alcohols from ketones. Prochiral ketones like 2-methyl cyclohexanone are, however, only poorly accepted, despite CPCR2's large substrate spectrum. The substrate spectrum of CPCR2 was investigated by selecting five amino positions (55, 92, 118, 119 and 262) and exploring them by single site-saturation mutagenesis. Screening of CPCR2 libraries with poor (14 compounds) and well-accepted (2 compounds) substrates showed that only position 55 and position 119 showed an influence on activity. Saturation of positions 92, 118 and 262 yielded only wild-type sequences for the two well-accepted substrates and no variant converted one of the 14 other compounds. Only the variant (L119M) showed a significantly improved activity (7-fold on 2-methyl cyclohexanone; v max 5 33.6 U/mg, K m 5 9.7 mmol/l). The L119M substitution exhibited also significantly increased activity toward reduction of 3-methyl (>2-fold), 4-methyl (>5-fold) and non-substituted cyclohexanone (>4-fold). After docking 2-methyl cyclohexanone into the substratebinding pocket of a CPCR2 homology model, we hypothesized that the flexible side chain of M119 provides more space for 2-methyl cyclohexanone than branched L119. This report represents the first study on CPCR2 engineering and provides first insights how to redesign CPCR2 toward a broadened substrate spectrum.
Introduction
Biocatalysis enables novel and innovative production of chemicals with high regioselectivity and stereoselectivity under often environmentally friendly conditions (Huisman et al., 2010; Wohlgemuth, 2010a; Nestl et al., 2011) . Especially, the asymmetric reduction of prochiral ketones to the corresponding enantiomerically pure alcohols by carbonyl reductases (CRs) or alcohol dehydrogenases (ADHs; EC 1.1.1.1) display a very attractive synthesis route to these important building blocks used in chemical and pharmaceutical industries (De Wildeman et al., 2007; Patel, 2008; Matsuda et al., 2009; Wohlgemuth, 2010b; Zheng and Xu, 2011) .
The particularly versatile NADH-dependent CR CPCR2 (Jakoblinnert et al., 2012) from Candida parapsilosis was first isolated from the strain DSM 70125 and characterized by Peters et al. (1993a) . The identical enzyme was later isolated from a related strain IFO 0369 and expressed in Escherichia coli by Yamamoto et al. (1999) . The homodimeric CPCR2 consists of two subunits (each 36 kDa) and belongs to the medium-chain and zinc-containing ADH family. The wild-type enzyme was recombinantly expressed in E. coli and employed in several synthetic setups to produce high value-added chiral alcohols like (R)-1,3-butanediol by racemic resolution (Matsuyama et al., 2001; Yamamoto et al., 2002a) and ethyl (R)-4-chloro-3-hydroxybutanoate by asymmetric reduction of the corresponding ketone (Yamamoto et al., 2002b) . Furthermore, CPCR2 preparations were utilized to obtain (S)-ethyl-hydroxyesters (Peters et al., 1993a) and propargylic alcohols (Schubert et al., 2001) . Additionally, wtCPCR2 was used to validate an enzyme-membrane reactor (Laue et al., 2001) , an enzyme emulsion reactor (Liese et al., 1998 ) and a biphasic minireactor (van den Wittenboer et al., 2009) . Recently, we have employed CPCR2 in E. coli whole cells in neat organic substrates and in absence of any additional solvent with yields up to 500 g/l enantiopure alcohol (Jakoblinnert et al., 2011) .
CPCR2 has a broad substrate spectrum and exhibits generally high enantiomeric excess (ee . 95%) (Prelog, 1964; Peters et al., 1993a, b; Yamamoto et al., 1999; Schubert et al., 2001) . It was only recently distinguished from the isoenzyme CPCR1, which has a narrow substrate spectrum (Jakoblinnert et al., 2012) .
Key for substrate acceptance is the general shape of the binding pocket. CPCR2's binding pocket was proposed to be composed of a small pocket with high affinity to small alkyl groups and a larger pocket accommodating small methyl and ethyl groups but preferably aromatic groups (Peters et al., 1993b) . The latter architecture is in agreement with the common fold of the substrate-binding pocket of zincdependent medium-chain ADHs (Knoll and Pleiss, 2008) .
Despite the broad substrate spectrum of CPCR2, there are classes of prochiral ketones which are only poorly converted, like ortho-substituted acetophenones, 2-methyl cyclohexanone (2-MCHone) or ketones carrying bulky side chains neighboring the carbonyl function (see Fig. 1 ; right box) (Peters et al., 1993b) . These substrates are generally difficult to be accepted by ADHs (Groger et al., 2006) . The corresponding (S)-alcohols of the poorly accepted substrates represent, however, industrially valuable synthons like (S)-2-chlorophenylethanol derivates, which serve as key intermediates for anticancer drugs (Patel, 2008) .
Consequently, there is a demand to enlarge the substrate scope of CPCR2 toward substrates as depicted in Fig. 1 (right box).
Tailoring of substrate scope can be achieved by rational design of the substrate-binding pocket, random mutagenesis or combinations thereof. Structurally guided exchanges of amino acids that affect substrate-and stereospecificity require a crystal structure or a reliable homology model. For example, Green et al., (1993) could increase activity of ADH1 from bakers' yeast up to 10-fold for hexanol oxidation by enlarging the substrate-binding pocket. Unlike rational design, random mutagenesis allows to discover mutations, which are located more distantly from the active site as shown for AdhA from Pyrococcus furiosus (Machielsen et al., 2008) . Recently, the activity of a CR for an unnatural substrate was increased by 3000-fold after including 19 substitutions in a directed evolution campaign .
In this study, we used a semi-rational approach targeting five amino acid residues to improve CPCR2 activity toward 14 poorly accepted substrates. Widening the substrate spectrum will make CPCR2 an attractive catalyst in organic synthesis and will possibly provide a deeper understanding about the underlying structure -function relationships that govern acceptance of cyclic ketones.
Materials and methods

Preparation of chiral standards
Preparation of the four stereoisomers of 2-methyl cyclohexanol (2-MCHol) was done by stereoselective reduction of 2-MCHone with carrot root as described previously (Baldassarre et al., 2000) . The conversion was monitored by gas chromatography (GC) and compared with commercial standards cis-and trans-2-MCHol. The major peaks were assigned to the (S)-alcohol.
Molecular modeling
Homology modeling of wild-type CPCR2 (wtCPCR2) was performed previously (Jakoblinnert et al., 2012) . Docking studies were performed on a closed dimer of the modeled wtCPCR2 structure and relaxed models of wtCPCR2, CPCR2-L119M with Zn-bound 2-MCHone in a reactive conformation were constructed. All energy calculations were performed using the modeling suite YASARA (Krieger et al., 2002) employing AMBER03 force field (Duan et al., 2003) for the protein and GAFF (Wang et al., 2004) with AM1/BCC charges (Jakalian et al., 2002) for the substrates.
All residues within 15Å radius of the bound alcohol were free to move. The active site above the bound NAD(H) is located at the interface between the two monomers possessing Rossmann-fold. The Zn-bound alcohol-ligand in the active site of the homology models was manually replaced by the respective substrates in their keto form and relaxed using cycles of steepest descent energy minimization and simulated annealing molecular dynamics (MD) simulations from 298K to 5K. Reference calculations for binding energies were performed using the respective substrates in a water box and the apo-enzyme with water coordinated to the catalytic Zn 2þ . The stabilization energies of the substrates in a catalytic orientation were calculated by subtracting the solvation energy for the substrate from the energy in the Zn 2þ bound state and the energy difference of an active site subset consisting of 10 residues lining the binding pocket in the substrate bound state versus the apo-structure with bound water (S46, V50, L55, W116, L119, L262, F285, W286, GB272, LB276, B denote amino acid of the other monomer).
Cloning of CPCR2 into pET22
The CPCR2 gene construct was newly designed with an N-terminal extension consisting of a protease recognition site for tobacco etch virus protease, an alanine decamer as spacer helix and a streptavidin affinity tag for convenient purification. The gene sequence was retrieved from Genbank accession number AB010636. The CPCR2 DNA construct was synthetically produced applying codon optimization for E. coli (GeneArt, Invitrogen, Darmstadt, Germany). The gene construct was cloned into pET22b þ vector (Invitrogen, Darmstadt, Germany) with NdeI and NotI restriction enzymes and T4 ligase. The attachment of the N-terminal extension had no influence on activity with acetophenone when Fig. 1 . Substrates reported for CPCR2 and normalized to ethyl 5-oxo-hexanoate reduction (Peters et al., 1993b) . Substrates, which are well accepted (.50% relative activity), are grouped in the left box, substrates, which are poorly accepted (,20% relative activity), are displayed in the right box. The relative activities were determined using ethyl-5-oxohexanoate as reference substrate. X: hydroxyl group, or halide (-Cl, -Br, -F) and n indicates the number of carbons in the chain (n: 1 to 4). compared with the originally cloned CPCR2 (data not shown).
Site-saturation mutagenesis
Degeneracy at five selected sites (L55, P92, G118, L119, and L262) was introduced by site-saturation mutagenesis using degenerated primer sets and a two-step protocol for polymerase chain reaction (PCR) adapted from Wang and Malcolm (1999) . Herein, Phusion High Fidelity DNA polymerase (New England Biolabs) was applied with 20 ng of template DNA. First, PCR with single primers was run followed by a second PCR were primer pairs were mixed again. NNN codon degeneracy was employed to cover all 64 possible codons. Primer pairs used for PCR are listed in Table I .
Sites of saturation mutagenesis are in italics
Digestion of template DNA ( pET22b-CPCR2) was done by addition of 20 U DpnI (New England Biolabs) to 50 ml PCR product and incubation at 378C overnight. Purified PCR products were transformed to E. coli BL21 (DE3) by electroporation and plated on agar plates containing 100 mg/ml ampicillin.
Mutant library generation
Quality of the library was analyzed by sequencing seven random clones from each saturated position. Per amino acid position, about 240 clones represent all possible codons with a probability of 95% (Firth and Patrick, 2008) . High-quality libraries (,30% wild-type occurrence) were constructed by transferring single colonies from agar plate to 96-well microtiter plates (flat bottom, polystyrene) filled with 100 ml lysogeny broth (LB) medium supplemented with 100 mg/ml ampicillin. Plates were tightly sealed and incubated (16 h, 378C, 900 rpm, 70% humidity). For long-term storage, 100 ml of 50% (v/v) glycerol was added to each well and the libraries were stored at 2808C.
CPCR2 protein expression in microtiter plate
Expression in microtiter plates was performed by preparing a pre-culture using 10 ml of glycerol stock to inoculate 140 ml of LB medium supplied with ampicillin (100 mg/ml) in 96-well plates (flat bottom, polystyrene). Plates were closed with lids, tightly sealed and incubated for 16 h (378C, 900 rpm, 70% relative humidity). Then, 10 ml of the preculture were transferred to 140 ml terrific broth (TB) medium ( per liter: 12 g Tryptone, 24 g yeast extract, 4 ml glycerol, 0.017 M KH 2 PO 4 , 0.072 M K 2 HPO 4 ) supplied with ampicillin 100 mg/ml (V-bottom, polystyrene) and incubated (1 h, 378C, 900 rpm, 70% relative humidity).
Expression was initiated by supplementing 10 ml isopropylthiogalactoside (IPTG) at 0.1 mM final concentration. Subsequently, protein expression took place for 6 -8 h at 158C at 900 rpm. For storage at 2208C, cells were pelleted (18 350 g, 10 min, 48C) and medium was removed. For lysis, 150 ml of lysis buffer (50 mM K 2 HPO 4 , 300 mM NaCl, 5 mg/ml lysozyme, pH 8.0) was added in each well. Cell pellets were mechanically lysed by pipetting up and down 100 times applying a 96-well liquidator 96 pipetting tool (Steinbrenner Laborsysteme GmbH). Afterwards, the suspension was incubated (1 h, 378C, 900 rpm, 70% relative humidity) to intensify enzymatic cell wall destruction by lysozyme. Measurements were performed with cleared lysate after centrifugation (18350 g, 10 min, 48C).
CPCR2 protein expression in flasks
Batch expression of CPCR2 was carried out in 250 ml TB medium with ampicillin (100 mg/ml) inoculated with 4 ml of an overnight culture grown in LB medium with ampicillin (100 mg/ml; 378C, 250 rpm). When cell density reached 0.6-0.8 OD 600 , expression was induced by supplementing 0.1 mM IPTG. Final expression was carried out overnight (158C, 250 rpm). Cells were harvested by centrifugation (2820 g, 10 min, 48C) and resuspended in four volumes of lysis buffer (50 mM K 2 HPO 4 , 300 mM NaCl, pH 8.0). Mechanical lysis was performed by sonification three times (1 min, 40% amplitude with 40 cycles, Bandelin M73 sonotrode). Supernatant containing the soluble CPCR2 was clarified by centrifugation (2820g, 10 min, 48C) and used for subsequent experiments.
CPCR2 protein purification
Crude cell extract was applied to affinity chromatography employing a streptavidin gravity column (Strep-Tactin w Sepharose, IBA TAGnology). Purification was performed according to the manufacturer's instructions. Elution fractions were analyzed by SDS-PAGE and CPCR2 concentrations were determined with the Bradford assay employing bovine serum albumin as standard. Fractions showing high enzyme activity were pooled and used for further measurements.
CPCR2 activity assay in microtiter plate
The NADH depletion assay in microtiter plate format was performed spectrophotometrically (Tecan Infinite M1000). Here, 50 ml of crude extract was mixed with 150 ml of a substrate cocktail (see Supplementary material) in 100 mM triethanolamine (TEA) at pH 8.0. The reaction was initiated by addition of 50 ml of 5 mM NADH and absorption was monitored at 340 nm for 5 min (1 ¼ 6 200 M 21 cm
21
). Instrument and solutions were prewarmed to 308C.
CPCR2 activity assay in cuvette
CPCR2 activity assay in cuvette format was carried out in a Cary 300 UV/Vis spectrophotometer (Varian). Varying concentrations of substrate were mixed with 0.3 mM NADH in 100 mM TEA, pH 8.0. The reaction was initiated by transferring 10 ml of CPCR2 solution of appropriate dilution to the cuvette and flushing with 990 ml of the substrate solution. The absorption at 340 nm was monitored for 2 min at 308C (1 ¼ 6 200 M 21 cm
21
). The data were fitted using SIMFIT, version 6.3.2 and all measurements were conducted in triplicate (Holzhutter and Colosimo, 1990 ).
Determination of temperature and pH-optimum
To determine the effect of temperature on the activity, CPCR2 assays were performed in cuvette format at temperatures from 18.5 to 47.88C with acetophenone as substrate. Twelve temperatures were taken into account and measurements were carried out in triplicate. To determine the kinetic parameters, enzyme assays were done in cuvette format with 2-methyl cyclohexanone with concentrations ranging from 0 to 40 mM. At least 10 different concentrations were applied for each data set and each set was performed in triplicate. To determine the effect of pH on activity, enzyme assays were performed in microtiter plate at pH 6.5 -9.5 with acetophenone as substrate in triplicate.
Asymmetric reduction of 2-methyl cyclohexanol
For reduction of 2-MCHone, 40 ml buffer (100 mM TEA, pH 8.0) were mixed with 10% (v/v) isopropanol, 10 mM NADH and 500 ml 2-MCHone (0.94 mM). Finally, purified wtCPCR2 (2 U) or CPCR2-L119M (30 U) were supplemented. The reaction was stirred (500 rpm, 308C) until maximum conversion was reached. Conversion was monitored by nonchiral GC. Educts and products were extracted three times with 50 ml CH 2 Cl 2 . Excess CH 2 Cl 2 and isopropanol were removed by evaporation under reduced pressure.
Determination of conversion, enantiomeric and diasteromeric excess
Non-chiral GC analysis. Conversion of 2-MCHone was monitored using Agilent GC device (HP5890 Series II) equipped with a flame ionization detector and a chiral column (FS-Cyclodex beta-I/P column 25 m, 0.25 mm, CS Chromatographie) at 10 psi nitrogen gas. The temperature program was 1208C, 4 min, isothermal. Substrates were separated from products and typical retention times were determined for 2-MCHone (3.2 min), trans-2-MCHol (3.5 min) and cis-2-MCHol (3.7 min). The molecular identity of the individual peaks was validated by comparison with commercially available standards (racemic cis-2-MCHol, racemic trans-2-MCHol, purchased from Sigma-Aldrich).
Derivatisation of 2-methyl cyclohexanols for chiral GC. Conversion mixtures were extracted with CH 2 Cl 2 (three times; 50 ml), dried (MgSO 4 ; 30 min), filtrated, concentrated to a final volume of 500 ml and supplemented with 3 ml CH 2 Cl 2 (dried with MgSO 4 ). Derivatization was initiated by supplementing 2.8 ml of trifluoroacetic anhydride (excess in molarity: 5-fold) and incubated (608C, 30 min; slowly stirred) under argon gas. Residual trifluoroacetic acid and CH 2 Cl 2 were removed subsequently by evaporation under reduced pressure. As control the identical procedure was performed for the commercial racemic mixture of cis and trans 2-MCHol (Simga-Aldrich).
Chiral GC analysis. Enantiomeric and diastereomeric excess of the biotransformation was determined by applying derivatised 2-MCHol. The instrument (Focus GC, Thermo Scientific) equipped with a Chirasil-Dex-CB column (25 m Â 0.25 mm, CS Chromatographie) at 0.7 bar helium. The temperature program was 508C/1 min-808C/15 min-1608C, 10 min.
The identity of the single peaks was validated by comparison of the peaks with GC-standards, which were synthesized earlier.
Typical retention times were determined for 1-(S), 2-(R) 2-MCHol (21.4 min), 1-(R), 2-(S) 2-MCHol (22.5 min), 1-(S), 2-(S) 2-MCHol (22.2 min), and 1-(R), 2-(R) 2-MCHol (22.9 min). Chiral standards for all stereoisomers of 2-MCHol were produced according to Baldassarre et al. (2000) applying biotransformation of 500 ml 2-MCHone with 200 g chopped carrot root (Daucus carota) resuspended in 200 ml tap water.
Results and discussion
Rational site selection for saturation mutagenesis in wtCPCR2
The reported crystal structure of a homologous ADH (35% sequence identity) from Sulfolobus solfataricus (SsADH, PDB: 1R37 (Esposito et al., 2003) ) was used as 'closest relative' for selecting amino acid positions for site saturation mutagenesis. Furthermore, the comprehensive medium-chain dehydrogenase/reductase engineering database was consulted (Knoll and Pleiss, 2008) and an alignment of 37 crystal structures of zinc-containing medium-chain ADHs was analyzed for variable regions within the substrate-recognition site (SRS). Two such regions were recognized and termed SRSI ('ceiling') and SRSII ('right wall'). Finally, five amino acid residues (L55, P92, G118, L119, L262) within or near these regions were selected for semi-rational design of the substrate-binding pocket and targeted in five single-site saturation experiments (see Fig. 2 ). Amino acids L55, G118 and L119 are located in the SRSI region, amino acid P92 is found in the SRSII region and amino acid L262 is situated at the substrate entrance channel. Probing positions in four different regions (substrate entrance (L262), 'ceiling' (Leu55, L119), 'right wall' (P92), second coordination sphere (G118)) will reveal which regions are important for substrate acceptance in CPCR2.
Unique for wtCPCR2 is the occurrence of the amino acid proline at position 92 within SRSII; all related ADH-enzymes contain a tryptophan or a phenylalanine at the corresponding position. Mutations of this position had an impact on substrate acceptance in ADHs from horse liver (F93) (Rubach and Plapp, 2002; Plapp, 2010) , yeast (W93) (Creaser et al., 1990) , Sulfolobus solfataricus (W95) (Pennacchio et al., 2009 ) and human liver (F93) (Hurley and Bosron, 1992) .
Residues located in SRSI ('ceiling') were reported to be variable among ADHs and held responsible for differences in substrate acceptance in individual ADHs (Knoll and Pleiss, 2008) . The positions L55, G118 and L119 selected for saturation mutagenesis in wtCPCR2 correspond to L58, G119 and I120 in the closely related SsADH and are reported to exhibit substrate contact or to be in close proximity to the co-crystallized substrate (Esposito et al., 2003) .
Amino acid L262 at the substrate entrance channel corresponds to amino acid L272 in SsADH, which is in direct contact with the substrate (Esposito, et al., 2003) . Mutation at this position exhibits impact on substrate acceptance like reduced activity on 2-butanol in ADH of Thermoanaerobacter ethanolicus (Y267G) (Ziegelmann-Fjeld et al., 2007) and a 7-to 10-fold increased activity for the substrates butanol, pentanol and hexanol in ADH1 from Saccharomyces cerevisiae (M294L) (Ganzhorn et al., 1987) , respectively.
Screening of saturation mutagenesis libraries with substrates acetophenone and 2-butanone and identification of improved variants
A first screening of the five libraries obtained from saturation mutagenesis was done with acetophenone as large and 2-butanone as small substrate (standarad deviation of the assay ,15%). As wild-type CPCR2 (wtCPCR2) accepts both substrates very well (Peters et al., 1993b) . This was done to investigate the importance of the selected amino acids for the catalytic machinery. Sequencing of the seven most active clones from each library revealed that no exchanges occurred at positions 92, 118, 119 and 262 indicating that, with regard to the conversion of the two selected substrates, the amino acids placed in these positions in wtCPCR2 provide optimal performance. However, two variants with 30% higher activity towards 2-butanone than wtCPCR2 were identified after saturation mutagenesis on amino acid 55. Here, leucine was exchanged for phenylalanine and tryptophan. The activity of both variants on acetophenone was comparable to wild type.
The exchange from an aliphatic leucine to an aromatic phenylalanine or tryptophan narrows the available space in the substrate-binding pocket and by this promotes conversion of the small substrate 2-butanone. This can be deduced from the finding of Green et al. (1993) that tight binding of small substrates by ADH1 from baker's yeast is 'disturbed' upon enlargement of the substrate binding pocket, and the report of Ziegelmann-Fjeld et al. (2007) where a more than 10 times increased K m for 2-butanol was found for a W267A variant of ADH from Thermoanaerobacter ethanolicus. The finding that reduction of acetophenone was not affected by reduction of the substrate site was somewhat surprising, but might be explained by probable beneficial interactions of the p-systems of the substrates and the amino side chains of phenylalanine and tryptophan.
Screening with 14 poorly accepted substrates and identification of improved variants
For fast and efficient screening of the five libraries from site saturation mutagenesis for improved conversion of poor substrates, conversion of 14 different substrates by purified wtCPCR2 was determined (NADH depletion assay, see Table SI ), and the substrates exhibiting ,20% activity relative to acetophenone were combined to four sets of substrate mixtures with a combination of three or four substrates each. Towards each set wtCPCR2 showed ,15% relative activity (see Table SII ). The libraries from site-saturation mutagenesis were screened with these substrate mixtures for activity and variants with the highest activity were re-screened with single substrates of the respective mixture. Two variants from library L119 showed a significantly improved activity ( 2-fold) with 2-methyl cyclohexanone (2-MCHone) when compared with wild type.
Analysis of the DNA sequence of both variants revealed a nucleotide exchange from cytosine to adenine resulting in an amino acid replacement from leucine to methionine. Exchanges to methionine are generally rare events since this amino acid is encoded by only one nucleotide triplett. The substitution leucine to methionine is evolutionary the most conservative one, since it has the highest score of þ2 in BLOSUM substitution matrix (Henikoff and Henikoff, 1992) .
Substrate specificity and selectivity
The variant CPCR2-L119M and wtCPCR2 were purified to homogeneity and analyzed in more detail with regard to substrate profile and catalytic parameters (SDS-PAGE, see Fig. S1 ).
The catalytic activities toward acetophenone as reference substrate, cyclohexanone and substituted cyclohexanones are illustrated in Fig. 3 . Notably, highest activity is observed for non-substituted cyclohexanone and activity drops in the course of 4-methyl, 3-methyl and 2-methly cyclohexanone. This trend is comparable between wtCPCR2 and variant L119M (e.g. wtCPCR2 from 3.0 (2-MCHone) to 18.3 U/mg (4-MCHone)//L119M from 8.5 (2-MCHone) to 95.6 U/mg (4-MCHone). The most significant improvement of specific activity was achieved toward 4-methyl cyclohexanone (5.2-fold higher than of wtCPCR2).
The catalytic parameters for reduction of 2-MCHone were estimated by measuring initial rate activities. The K m of CPCR2-L119M is similar to the one of wtCPCR2 (see Table II ), however, k cat is more than 7-fold higher under substrate saturation conditions (see Table II ). Optima in temperature and pH remain unchanged when comparing wtCPCR2 and CPCR2-L119M (see Figs S2 and S3) . Furthermore, the specific activity improvement of purified CPCR2-L119M towards 2-MCHone (see Fig. 3 ), correlates ) is depicted as black sphere and the substrate ethoxyethanol (ETX) and the cofactor NADH are represented as sticks. According to Knoll and Pleiss (2008) L55, G118 and L119 are located in SRSI and P92 in SRSII. The amino acid L262 is at the entrance channel.
Semi-rational CPCR2 design for cyclohexanones well with the activity improvement found in the library at position 119 by screening crude cell extracts with the substrate set containing the screening substrate 2-MCHone. Table III compares the kinetic parameters of wtCPCR2 and CPCR2-L119M for reduction of 2-MCHone with literature data for purified ADHs demonstrating a notably superior specific activity of variant CPCR2-L119M (.3-fold; Table III) .
Selectivity of wtCPCR2 and CPCR2-L119M was investigated in the reduction of 2-MCHone on analytical scale. The detected relative amounts of the four possible products and enantiomeric and diasteromeric excess are depicted in Table IV .
It was found that for both wtCPCR2 and CPCR2-L119M about half the generated product was the trans 1-R,2-R isomer. This is surprising since wtCPCR2 produces in general (S)-rather than (R)-alcohols. A significant difference in selectivity of wtCPCR2 and CPCR2-L119M was found with regard to the cis-products (1-R, 2-S and 1-S, 2-R). In particular, variant CPCR2-L119M produced an about 3-fold higher amount of 1 -R, 2-S than wtCPCR2 resulting in a slightly higher enantiomeric excess.
For synthetic application of wtCPCR2 or CPCR2-L119M selectivity for 2-MCHone reduction is too low and needs to be improved. However, product mixtures of 2-MCHol were reported previously for horse liver ADH (Jones and Takemura, 1982) 
Structure-function relationships and substrate docking
A role of position 119 in substrate recognition of CPCR2 can be deduced from the corresponding position 141 in distantly related ADH isoenzymes from human liver (29% sequence identity). The ADH isoenzymes (b 1 b 1 //ss) show different responses to pyrazole-like inhibitors, wherein the ss isoenzyme has low affinity to 4-methylpyrazole and the b 1 b 1 isoenzyme exhibits high affinity. This is modulated by position 141 as was shown by the exchange of M141 in ss-ADH to L141 as in native b 1 b 1 -ADH, which resulted in 35-fold increase in affinity to 4-methylpyrazole (Xie and Hurley, 1999) . Additionally, the substrate spectrum of the ss-M141L variant toward primary alcohols (C 2 -C 6 ) was affected. Maximal activity was decreased for all employed alcohols and K m values showed an increase from C 2 to C 4 and a decrease for C 5 and C 6 .
Inhibitory effects and changes in substrate specificity were attributed to changes of the available space within the substrate-binding pocket by a M141L substitution and not to an altered transition state (Xie and Hurley, 1999) . Whether this is also the case for the CPCR2 variant can be investigated by docking 2-MCHone into the substrate-binding pocket of wtCPCR2 and CPCR2-L119M.
The 'best' active site mutation for increased activity toward 2-MCHone was the replacement of leucine to methionine at position 119. To elucidate structure -function relationships, substrate docking was performed for the screening substrate 2-MCHone in pro-cis orientation within the substrate-binding pocket of wtCPCR2 and CPCR2-L119M based on PDB-1R37 (Esposito et al., 2003) . Figure 4 shows 2-MCHone, the catalytic zinc ion as well as the NADH cofactor and the amino acid residue 119. Computational studies revealed differences in the orientation of 2-MCHone and side chain conformation of amino acids at positions 119 in the two enzymes. The positioning of 2-MCHone in CPCR2-L119M compared with wtCPCR2 is almost unaltered, but the terminal methyl group of the methionine in Fig. 3 . Specific activities of wtCPCR2 and CPCR2-L119M on acetophenone and various cyclohexanones. Activities were determined at 5 mM substrate concentration employing the standard NADH-depletion assay; measurements were conducted in triplicate. CPCR2-L119M points away from the 2-methyl group of 2-MCHone, whereas the isobutyl side chain of leucine in wtCPCR2 sterically constrains the 2-methyl group of 2-MCHone. The replacement of leucine for methionine may therefore provide more flexibility to the binding and release of 2-, 3-, 4-MCHones and cyclohexanone resulting in higher catalytic activity of CPCR2-L119M (Fig. 3) Table V ) indicate for both wtCPCR2 and CPCR2-L119M that cyclohexanone is preferred over the methyl-substituted cyclohexanones; the screening substrate 2-MCHone has the most unfavorable stabilization energy. This is in good agreement with the experimental data (see Fig. 3 ).
Stabilization energies are between 6 and 26 kJ/mol lower in CPCR2-L119M than in wtCPCR2 and therefore considerably improved. Again this fits well to the catalytic performance of wtCPCR2 and CPCR2-L119M toward the examined substrates ( Fig. 3 and Table V) . Thus, there is a good correlation between calculated stabilizing energies and experimentally determined specific activities.
The computational study can also partially explain the enantiomeric preference of wtCPCR2 and CPCR2-L119M in the conversion of 2-MCHone (Table IV and Fig. 4) . CPCR2-L119M yields 3-fold more cis-1-R,2-S 2-MCHol (see Table IV ) which can likely be attributed to the pro-cis orientation of the 2-MCHone in the binding pocket. The L119M substitution generates 'free space' for the 2-methyl group of 2-MCHone since the branched isobutyl side chain is replaced by a non-branched methionine side chain. However, for a detailed study, all binding modes of 2-MCHone (cis, trans isomers, chair and boat conformation) would have to be considered and a crystal structure in which cyclohexanol or similar substrates are bound to an ADH and that could serve as promising starting structure to elucidate enantiopreferences would be required; to our knowledge, there is no such structure to date.
Conclusions
This work represents the first study wherein amino acid positions of a CR from Candida parapsilosis (wtCPCR2) responsible for substrate recognition were rationally identified and subjected to saturation mutagenesis and screening. The screening system developed for this purpose is based on NADH-depletion and was optimized for homogeneous expression of wtCPCR2 in 96-well microtiter plates with a standard deviation of 15%. It can most likely be employed for other ADHs with only minor modifications. It was demonstrated that for broadening the substrate scope toward reduction of branched 2-MCHone the amino acid in position 119 plays a crucial role. Substitution of leucine for methionine in that position boosted the specific activity toward 2-MCHone by up to 7-fold. The variant CPCR2-L119M is 3-fold more active in the conversion of 2-MCHone than any ADH investigated with this substrate so far. If selectivities can be further improved, CPCR2-L119M could become a synthetically attractive catalyst for the production of chiral cyclohexanol moieties occurring in complex compounds like menthol.
The effect of the single mutation L119M on activity and selectivity could partially be interpreted on the molecular level by comparing stabilization energies and taking the pro-cis orientation of 2-MCHone into account. Saturation mutagenesis at position 119 and the identified L119M substitution represent a first hint that a conservative substitution in close proximity to the active site could be important to broaden the substrate profile and/or preserve catalytic activity.
